Time Session
18:30 - 21:00
The Reception
The Wellcome Collection, 183 Euston Road, London NW1 2BE

Main Agenda

All main agenda presentations will take place in the Biotech Investment Room.

1:1 meetings take place throughout the day and are pre-booked online. 

Login to add your profile, bookmark prospects and book meetings. You can add agenda items to your online meeting schedule - just click item name, then 'Join'.

May 9

Time Session
08:15 - 09:00
Registration and Breakfast

Full continental breakfast is served

09:00 - 09:05
Welcome

Mattias Johansson, Director, Ezenze Ltd, and Anglonordic Conference Founder

09:05 - 09:30
Keynote
Biotech Investment Room

Gil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jefferies

09:30 - 10:30
Investor Panel

What’s hot and what's simmering?

Panel discussion on Investment trends, chaired by Lisa Urquart, Editor, EP Vantage

Speakers include:

  •  Hakan Goker, Senior Investment Director, M Ventures
  •  Stephan Christgau, Senior Partner, Novo Seeds
  •  Henrijette Richter, Managing Partner, Sofinnova
  •  Roel Bulthuis, Managing Director, INKEF Capital
10:30 - 11:00
Coffee

11:00 - 12:30
Biotech Company Presentations

11:00 Cumulus Oncology

11:15 VAXIMM

11:30 Prophylix Pharma

11:45 In4Derm (Univ. Dundee)

12:00 Sartar Therapeutics

12:15 Adenium Biotech

12:30 - 13:30
Networking Lunch
13:30 - 14:30
Technologies and treatments - What’s on the horizon?

Panel Discussion, chaired by Lucie Ellis, Editor, In Vivo

Speakers include:

  •  Niall Martin, CEO, Artios Pharma
  •  Ian Wilson, CEO, ImaginAB
  •  Sue Herbert, Head of Strategy, Merck
  •  Dirk Beher, CEO and Founder, Asceneuron SA
14:30 - 15:45
Biotech Company Presentations
Biotech Investment Room

14:30 Reneuron

14:45 Antagonis Biotherapeutics

15:00 NMD Pharma

15:15 Ablatus

15:30 ISA Pharma

15:45 - 16:00
Coffee
16:00 - 16:45
Challenges and opportunities for Women in European Biotech and Medtech
16:45 - 17:45
If I knew then what I know today

Panel Discussion chaired by Mike Ward, Chief Content Officer, Datamonitor Healthcare & Scrip Intelligence

Speakers include:

  • Anker Lundemose, CEO, Mission Therapeutics
  • Edwin Moses, Chairman, Serial entrepreneur and value creator
  • Louise Makin, CEO, BTG
  • Ian Nicholson, CEO, F2G
17:45 - 17:55
Conclusions

Technology Room

May 9

Time Session
11:00 - 12:30
Technology Company Presentations
Technology Room

11:00 Virokine Therapeutics

11:15 Pila Pharma

11:30 Medherant

11:45 MediSieve

12:00 Zerion

12:15 Censo Biotechnologies

14:30 - 15:45
Technology Company Presentations
Technology Room

14:30 Biotec Pharmacon

14:45 CLS

15:00 SIME Clinical AI

15:15 Indi Molecular

15:30 GTN